Why Is Bio-Rad (BIO) Up 7.8% Since Last Earnings Report? [Yahoo! Finance]
![Yahoo! Finance](../../../Content/images/providers/Yahoo! Finance.png)
Bio-Rad Laboratories, Inc. Class A (BIO)
Last bio-rad laboratories, inc. class a earnings: 2/13 04:15 pm
Check Earnings Report
US:NYSE Investor Relations:
bio-rad.com/en-us/corporate/investor-relations
Company Research
Source: Yahoo! Finance
Will the recent positive trend continue leading up to its next earnings release, or is Bio-Rad due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important drivers. Bio-Rad Q1 Earnings Surpass Estimates, Margins Down Bio-Rad posted first-quarter 2024 adjusted earnings per share of $2.29, beating the Zacks Consensus Estimate by 12.3%. However, the bottom line declined 31.4% from the prior-year quarter's levels. The quarter's adjustments eliminate the impacts of certain non-recurring items like the amortization of purchased intangibles, Restructuring costs, gains/losses from the change in the fair market value of equity securities and gains/losses on equity-method investments. The company's GAAP EPS was $13.45 per share in the first quarter compared with GAAP earnings of $2.32 in the year-ago quarter. Revenues in Detail Revenues of $610.
Show less
Read more
Impact Snapshot
Event Time:
BIO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BIO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BIO alerts
High impacting Bio-Rad Laboratories, Inc. Class A news events
Weekly update
A roundup of the hottest topics
BIO
News
- Is It Wise to Hold Bio-Rad (BIO) Stock in Your Portfolio Now? [Yahoo! Finance]Yahoo! Finance
- Non-Viral Transfection Reagents Market worth USD 1,157.5 Million to 2031 - Exclusive Report by InsightAce Analytic [Yahoo! Finance]Yahoo! Finance
- $842.7 Million SDS Poly Acrylamide Gel Electrophoresis Market Forecast, 2030 - Featuring Profiles of 13 Companies Including Abcam, Bio-Rad Laboratories, GE Healthcare, and Thermo Fisher Scientific [Yahoo! Finance]Yahoo! Finance
- Africa Malaria Diagnostics Market Size, Share & Trends Analysis Report 2024-2030: Adaptation of the "Zero Malaria" Agenda to Bolster Growth with Increased Initiatives by Market Players and Private Investors [Yahoo! Finance]Yahoo! Finance
- Proteomics Market to Reach $161.9 billion, Globally, by 2035 at 14.2% CAGR: Allied Market Research [Yahoo! Finance]Yahoo! Finance
BIO
Earnings
- 5/7/24 - Beat
BIO
Sec Filings
- 6/17/24 - Form 3
- 6/14/24 - Form 4
- 6/13/24 - Form 144
- BIO's page on the SEC website